Illumina, Inc. – Consenus Indicates Potential -5.6% Downside – DirectorsTalk Interviews

Illumina, Inc. – Consenus Indicates Potential -5.6% Downside  DirectorsTalk Interviews

Illumina, Inc. found using ticker (ILMN) have now 14 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price.

Source: Genome Sequencing